Accuracy of self-screening for contraindications to combined oral contraceptive use

Obstetrics and Gynecology

Volumn 112, Issue 3, 2008, Pages 572-578

  Grossman, Daniel ^a   Fernandez, Leticia ^b   Hopkins, Kristine ^b   Amastae, Jon ^b   Garcia, Sandra G ^b   Potter, Joseph E ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BIRTH CONTROL; BLOOD PRESSURE MEASUREMENT; BREAST CANCER; BREAST FEEDING; CHECKLIST; CHOLESTEROL BLOOD LEVEL; CONVENIENCE SAMPLE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; GALLBLADDER DISEASE; GROUPS BY AGE; HEART DISEASE; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; INTERVIEW; LIVER CANCER; LIVER DISEASE; LUNG EMBOLISM; MIGRAINE AURA; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SMOKING; STROKE; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; QUESTIONNAIRE;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 55949110311     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818345f0     Document Type: Article

References (14)

1. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004;350:1-36.
2. Grossman D, Ellertson C, Abuabara K, Blanchard K, Rivas FT. Barriers to contraceptive use in product labeling and practice guidelines. Am J Public Health 2006;96:791-9.
3. Trussell J, Stewart F, Potts M, Guest F, Ellertson C. Should oral contraceptives be available without prescription? Am J Public Health 1993;83:1094-9.
4. Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc 2008;48:212-21.
5. Zavala AS, Perez-Gonzales M, Miller P, Welsh M, Wilkens LR, Potts M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Stud Fam Plann 1987;18:284-90.
6. Yeatman SE, Potter JE, Grossman DA. Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico. Stud Fam Plann 2006;37:197-204.
7. Shotorbani S, Miller L, Blough DK, Gardner J. Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception 2006;73:501-6.
8. World Health Organization. Medical eligibility criteria for contraceptive use, 3rd ed. Geneva: WHO; 2004.
9. Clinical calculator 1. From an observed sample: estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios. Available at: http://faculty.vassar.edu/lowry/clin1.html. Accessed September 15, 2007.
10. Pleis JR, Coles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1998. Vital Health Stat 10 2002;209:1-113.
11. Shortridge E, Miller K. Contraindications to oral contraceptive use among women in the United States, 1999-2001. Contraception 2007;75:355-60.
12. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
13. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4.
14. Tatum C, Garcia SG, Goldman L, Becker D. Valuable safeguard or unnecessary burden? Characterization of physician consultations for oral contraceptive use in Mexico City. Contraception 2005;71:208-13.